Imperagen
PrivateLast Round
Seed
May 21, 2026
Total Funding Raised
$17.69M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Imperagen operates in Healthcare & Life Sciences and is based in Manchester. Its latest recorded funding round was a Seed round in May 2026.
Imperagen is a biotechnology company that provides a digital enzyme evolution platform to accelerate enzyme engineering for the pharmaceutical and chemical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imperagen Comparables
Compare Imperagen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymvol Biomodeling | 88% | |
| Ligo Biosciences | 87% | |
| Biomatter | 84% |
For institutional investors. Book with your work email.
Imperagen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 21, 2026 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Mar 14, 2024 | ||||
| Seed | Aug 2, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Imperagen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IQ Capital | Seed |
| Innovate UK | Grant |
| Northern Gritstone | Seed |
| PXN Ventures | Seed |
| PXN Group | Seed |
| PXN Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
$5M round led by PXN Group
- Jan 21, 2026
Grew 20% QoQ from 15 to 18 employees.
For institutional investors. Book with your work email.
Imperagen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imperagen's valuation, stock price, and market status.
Is Imperagen a public or private company?
Imperagen is a private company.
What is the current stock price of Imperagen?
Imperagen is a private company, so its shares have no public market price. Caplight tracks Imperagen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imperagen worth (valuation)?
Valuation information for Imperagen is not publicly available.
Can I buy Imperagen stock?
Imperagen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imperagen's last funding round?
Imperagen's most recent funding round was Seed on May 21, 2026.
Who are the main investors in Imperagen?
Key investors in Imperagen include IQ Capital, Northern Gritstone, PXN Ventures, PXN Group, PXN Ventures.
Will Imperagen IPO soon?
No public IPO plans have been announced for Imperagen.
How can I track Imperagen secondary market activity?
Caplight tracks bids, offers, and trades in Imperagen's shares on secondary markets.